This statistic shows the probability of success for new drugs in the U.S. through the various stages of development, from January 1, 2011, to November 30, 2020, by drug classification. It was found that the probability of success from phase I to phase II was quite similar for NMEs, biologics, and vaccines
Probability of success for new drugs in the U.S. by development phase between 2011 and 2020, by drug classification
Only company-sponsored, FDA registration-enabling development
programs were included in this analysis. Investigator-sponsored studies and combinations with other
investigational drugs were excluded.
* NDA - New Drug Application / BLA- Biologic License Application.
** NME - New Molecular Entity.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Biotechnology Innovation Organization, & Pharma Intelligence, & QLS Advisors. (February 26, 2021). Probability of success for new drugs in the U.S. by development phase between 2011 and 2020, by drug classification [Graph]. In Statista. Retrieved November 13, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/597850/drug-development-phases-probability-of-success-by-drug-classification-modality/
Biotechnology Innovation Organization, und Pharma Intelligence, und QLS Advisors. "Probability of success for new drugs in the U.S. by development phase between 2011 and 2020, by drug classification ." Chart. February 26, 2021. Statista. Accessed November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/597850/drug-development-phases-probability-of-success-by-drug-classification-modality/
Biotechnology Innovation Organization, Pharma Intelligence, QLS Advisors. (2021). Probability of success for new drugs in the U.S. by development phase between 2011 and 2020, by drug classification . Statista. Statista Inc.. Accessed: November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/597850/drug-development-phases-probability-of-success-by-drug-classification-modality/
Biotechnology Innovation Organization, and Pharma Intelligence, and QLS Advisors. "Probability of Success for New Drugs in The U.S. by Development Phase between 2011 and 2020, by Drug Classification ." Statista, Statista Inc., 26 Feb 2021, https://www-statista-com.ezproxy.canberra.edu.au/statistics/597850/drug-development-phases-probability-of-success-by-drug-classification-modality/
Biotechnology Innovation Organization & Pharma Intelligence & QLS Advisors, Probability of success for new drugs in the U.S. by development phase between 2011 and 2020, by drug classification Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/597850/drug-development-phases-probability-of-success-by-drug-classification-modality/ (last visited November 13, 2024)
Probability of success for new drugs in the U.S. by development phase between 2011 and 2020, by drug classification [Graph], Biotechnology Innovation Organization, & Pharma Intelligence, & QLS Advisors, February 26, 2021. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/597850/drug-development-phases-probability-of-success-by-drug-classification-modality/
